A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
NAC-preHD is a phase II randomized placebo controlled study of oral NAC among premanifest HD gene expansion carriers, with clinical and radiological outcome at three years.
Epistemonikos ID: 0ce866927379427c8ad9e20ed1f865cc0065ffaf
First added on: May 13, 2024